GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » IMCD NV (OTCPK:IMCDY) » Definitions » Cash, Cash Equivalents, Marketable Securities

IMCDY (IMCD NV) Cash, Cash Equivalents, Marketable Securities : $547 Mil (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is IMCD NV Cash, Cash Equivalents, Marketable Securities?

IMCD NV's quarterly cash, cash equivalents, marketable securities declined from Dec. 2023 ($430.17 Mil) to Jun. 2024 ($240.89 Mil) but then increased from Jun. 2024 ($240.89 Mil) to Dec. 2024 ($547.41 Mil).

IMCD NV's annual cash, cash equivalents, marketable securities increased from Dec. 2022 ($235.18 Mil) to Dec. 2023 ($430.17 Mil) and increased from Dec. 2023 ($430.17 Mil) to Dec. 2024 ($547.41 Mil).


IMCD NV Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for IMCD NV's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMCD NV Cash, Cash Equivalents, Marketable Securities Chart

IMCD NV Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 205.61 200.99 235.18 430.17 547.41

IMCD NV Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 235.18 238.12 430.17 240.89 547.41

IMCD NV Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


IMCD NV  (OTCPK:IMCDY) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


IMCD NV Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of IMCD NV's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


IMCD NV Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » IMCD NV (OTCPK:IMCDY) » Definitions » Cash, Cash Equivalents, Marketable Securities
Address
Wilhelminaplein 32, Rotterdam, NLD, 3072 DE
IMCD NV manufactures and sells a variety of chemicals and food ingredients. The firm's product portfolio consists of two categories: Life Science consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition, and Home Care and I&I, and The Industrial segment contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. The company has four operating segments; EMEA, Americas, Asia-Pacific, and Holding companies. It derives a majority of its revenue from the EMEA segment.

IMCD NV Headlines

From GuruFocus

Q3 2024 IMCD NV Earnings Call Transcript

By GuruFocus News 11-09-2024

Nine Months 2019 IMCD NV Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q3 2021 IMCD NV Earnings Call Transcript

By GuruFocus Research 02-13-2024

Royce Investment Partners Comments on IMCD

By Sydnee Gatewood Sydnee Gatewood 10-27-2020

Q2 2022 IMCD NV Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2020 IMCD NV Trading Update Call Transcript

By GuruFocus Research 02-13-2024

Q1 2024 IMCD NV Earnings Call Transcript

By GuruFocus Research 04-29-2024

Full Year 2019 IMCD NV Earnings Call Transcript

By GuruFocus Research 02-13-2024